| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| API & Intermediates |
Now Position:Home > Products > API & Intermediates < Anti-cancer API |
|
| Ponatinib(CAS:943319-70-8) |
 |
|
|
Product No. |
|
TP1246C |
|
Name |
|
Ponatinib |
|
Synonyms |
|
AP24534; 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide |
|
Structure |
|
,  |
|
Formula |
|
C29H27F3N6O |
|
Mol. Wt. |
|
532.56 |
|
CAS Number |
|
943319-70-8 |
|
Purity |
|
>99% | |
|
|
|
|
|
